search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS


Grant awarded for study into mesothelioma clinical decision-making


National charity, Mesothelioma UK, has awarded a grant for £25,000 for research that explores clinical decision-making in treatment pathways for mesothelioma patients at Oxford University Hospitals, Royal Berkshire, and Buckinghamshire NHS Foundation Trusts.


The recipient of the grant is Dr Catherine Henshall, senior nursing research fellow at Oxford Brookes University, who will carry out a study to develop an evidence-based, patient- centred approach to mesothelioma clinical decision-making.


Mesothelioma UK is committed to


supporting research into all aspects of treatment and care related to mesothelioma. The charity works with the National Lung Cancer Forum for Nurses (NLCFN) to make funding available for nurse-led mesothelioma research.


Around 2700 people in the UK are diagnosed


with mesothelioma, an incurable cancer caused by exposure to asbestos, each year.


Dr Henshall’s study will involve analysing patient records and reports to record diagnosis dates, treatments, mortality rates and clinical care team members. Statistical tests will then be applied to the information to identify any differences between the Trusts. The study will also involve


focus groups where members of the multi- disciplinary teams at the trusts will discuss how clinicians’ engagement with, and awareness of, current mesothelioma research impacts on clinical decision-making. Commenting on the study Dr Henshall said:


“We are delighted to have received this funding from Mesothelioma UK and the NLCFN. The


Young people set to benefit from lifesaving heart op


Thousands of people are set to benefit from an innovative new heart procedure to prevent strokes in younger people.


The new treatment, unveiled as part of the


NHS Long Term Plan, tackles ‘hole in the heart’ – or Patent Foramen Ovale (PFO) – a common condition which can trigger strokes. Thousands of people living with PFO in England live in fear of another stroke and this potentially lifesaving procedure helps remove the risk by closing the hole, giving people with the condition peace of mind about future health risks.


The new measure, to be available across


the country, is expected to benefit up to 1500 patients a year. Tackling major killer conditions such as stroke and heart attacks is a major part of the NHS Long Term Plan published earlier this year. Professor Stephen Powis, medical director for NHS England, said: “This truly lifesaving and life-changing procedure will now be available across the NHS, and will mean people can live without the worry of having a stroke. “As part of the NHS Long Term Plan, we will continue to test the most advanced procedures available anywhere across the globe, collecting real world evidence to ensure NHS patients receive world-class care while delivering value for the taxpayers’ pound.”


A PFO is a small flap-like opening between the top two chambers of the heart which helps with circulation when a baby is still in the womb.


It usually closes after birth, however can stay fully or partially open increasing stroke risk, where small blood clots pass through the hole and get stuck in the arteries of the brain. PFO usually does not cause any symptoms with the function of the heart, so it often is not picked up until someone suffers an event like a stroke or is tested for other conditions. Most people will not require surgery to close it or medication, unless they have other conditions such as a history of stroke, or have a high risk of developing blood clots. The new surgery involves a small device made up of two umbrellas joined at the centre put into the hole to close it up. The procedure normally takes around an hour and is performed under local anaesthetic and it costs around £8000 per patient.


Mark MacDonald, deputy director of policy at the Stroke Association, said: “Stroke can strike anyone at any time, changing people’s lives in an instant. The condition has a huge cost to a person’s health, independence and relationships, not to mention a huge cost to our NHS and care services. All stroke survivors should have the best possible chance of preventing another stroke and any further devastating impact. “This announcement is really welcome news: thousands could benefit from this latest procedure, and more people will be able to rebuild their lives with a reduced risk of experiencing another stroke.”


The life-changing procedure is among new treatments that are being made routinely available on the NHS.


10 I WWW.CLINICALSERVICESJOURNAL.COM


study will promote a joined-up approach to mesothelioma treatment that is consistent with local and national guidance, ensuring that decisions across the trusts are made using evidence, multi-disciplinary knowledge and shared clinical expertise. “We are committed to working closely and in partnership with Mesothelioma


UK throughout this project to ensure that the best outcomes for mesothelioma patients are identified and promoted, and to make a real and lasting difference to mesothelioma patient care and service delivery.” Dr Henshall will carry out her study from the Oxford School of Nursing and Midwifery at Oxford Brookes University.


NHS confirms ICS to serve more than 21 million


One in three people in England, 21 million, are set to benefit from improved health and care, as three new areas were announced as ‘integrated care systems‘ (ICS). According to NHS England, the North East and North Cumbria will become the country’s largest ICS, serving more than three million people alone.


South East London becomes the first ICS in the capital while Buckinghamshire, Oxfordshire and Berkshire West makes up the third new area where different health and care organisations work together to plan and join up services.


Each has shown that its partners all share a common vision to improve health and care, backed up by robust operational and financial plans, and proposals for collective leadership and accountability. They follow in the footsteps of the 12 earliest integrated care systems announced in 2018, plus two devolved health systems in Greater Manchester and Surrey. ICSs are already helping people to stay healthy and independent for longer, giving more care closer to where they live and work, and improving response times and performance in areas such as cancer and A&E.


These changes have been made possible by different organisations – NHS hospitals, GPs, councils, and care homes – joining forces to agree and plan for local people’s needs.


AUGUST 2019


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92